X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Unichem Lab Fact Sheet, Unichem Lab Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Unichem Lab Fact Sheet   (UNCHM)

Here is the latest financial fact sheet of Unichem Lab. For more details, see the Unichem Lab quarterly results and Unichem Lab share price and chart. For a sector overview, read our pharmaceuticals sector report.

UNICHEM LAB Price History

Price Rs 260.9
Mkt Cap Rs m 23,664
Vol '000 6.0
P/E X 23.5
P/CF X 16.1
EPS (TTM) Rs 11.1
% ch % -1.3
No. of shares m 90.70
% ch week % -2.8
% ch 1-mth % 2.0
% ch 12-mth % -3.7
52 week H/L Rs 319.9/239.1
(As on Jun 23, 2017 03:37:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

UNICHEM LAB Financials

No. of Mths
Year Ending
12
Mar-12
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
UNICHEM LAB EQUITY SHARE DATA
High Rs224217237268334 
Low Rs101124138182174 
Sales per share (Unadj.) Rs96.9119.5125.1132.4146.9 
Earnings per share (Unadj.) Rs7.912.518.78.311.9 
Diluted earnings per shareRs7.912.518.78.311.9 
Cash flow per share (Unadj.) Rs11.316.823.712.916.2 
Dividends per share (Unadj.) Rs3.004.508.002.002.00 
Adj. dividends per shareRs2.994.497.992.002.00 
Dividend yield (eoy) %1.82.64.30.90.8 
Book value per share (Unadj.) Rs73.180.490.195.6105.1 
Adj. book value per shareRs72.880.290.095.6105.3 
Shares outstanding (eoy) m90.3290.4690.6390.7790.84 
Bonus/Rights/Conversions  ESOPESOP--ESOP 
Price / Sales ratio x1.71.41.51.71.7 
Avg P/E ratio x20.613.610.027.121.4 
P/CF ratio (eoy) x14.410.27.917.515.7 
Price / Book Value ratio x2.22.12.12.42.4 
Dividend payout %38.036.042.824.116.8 
Avg Mkt Cap Rs m14,67715,42316,99320,41923,073 
No. of employees `0004.04.65.15.55.7 
Total wages/salary Rs m1,4011,6491,8742,2322,558 
Avg. sales/employee Rs Th2,188.72,353.72,208.22,181.52,352.5 
Avg. wages/employee Rs Th350.2359.1365.0405.2450.9 
Avg. net profit/employee Rs Th178.2246.6329.9136.8190.4 
UNICHEM LAB INCOME DATA
Net Sales Rs m8,75510,80811,33512,01813,346 
Other income Rs m102134423204192 
Total revenues Rs m8,85710,94211,75712,22213,538 
Gross profit Rs m1,1831,7431,7781,0131,639 
Depreciation Rs m304383457413390 
Interest Rs m4133323029 
Profit before tax Rs m9401,4611,7127741,412 
Minority Interest Rs m00000 
Prior Period Items Rs m0001-4 
Extraordinary Inc (Exp) Rs m004120-35 
Tax Rs m22832943021293 
Profit after tax Rs m7131,1321,6937541,080 
Gross profit margin %13.516.115.78.412.3 
Effective tax rate %24.322.525.12.820.7 
Net profit margin %8.110.514.96.38.1 
UNICHEM LAB BALANCE SHEET DATA
Current assets Rs m4,3944,7845,8075,6445,979 
Current liabilities Rs m2,3332,5112,3032,1182,432 
Net working cap to sales %23.521.030.929.326.6 
Current ratio x1.91.92.52.72.5 
Inventory Days Days6648666363 
Debtors Days Days7670635860 
Net fixed assets Rs m5,2125,8005,0985,3866,403 
Share capital Rs m181181181182182 
"Free" reserves Rs m6,3837,0457,9048,4249,293 
Net worth Rs m6,6067,2718,1668,6759,548 
Long term debt Rs m205209247204230 
Total assets Rs m9,86610,72511,44711,68712,843 
Interest coverage x24.045.454.726.550.0 
Debt to equity ratio x00000 
Sales to assets ratio x0.91.01.01.01.0 
Return on assets %7.610.915.16.78.6 
Return on equity %10.815.620.78.711.3 
Return on capital %14.420.025.69.114.3 
Exports to sales %25.529.828.830.529.2 
Imports to sales %7.44.65.64.16.3 
Exports (fob) Rs m2,2363,2163,2643,6663,900 
Imports (cif) Rs m651497634499847 
Fx inflow Rs m2,3293,3513,4204,0534,356 
Fx outflow Rs m7756429198721,162 
Net fx Rs m1,5552,7082,5013,1803,194 
UNICHEM LAB CASH FLOW
From Operations Rs m 1,241 1,712 867 781 1,119 
From Investments Rs m -1,018 -1,185 357 -523 -853 
From Financial Activity Rs m -142 -514 -949 -510 -334 
Net Cashflow Rs m 81 14 275 -252 -68 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 50.1%
Foreign collaborators 0.0%
Indian inst/Mut Fund 15.1%
FIIs 3.0%
ADR/GDR 0.0%
Free float 31.7%
Shareholders 20,176
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Unichem Bhavan, Prabhat Estate, Off. S. V. Road, Jogeshwari (W), Mumbai-02
E-MAIL subharamank@unichemlabs.com WEB www.unichemlabs.com
TELEPHONE (022) 6688 8333 FAX (022) 2678 4391
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C-13, Pannalal Silk Mills Cmpound, LBS Marg, Mumbai-78
AUDITOR B. D. Jokhakar & Co.
CHM: P. A. Mody (MD) COMP SEC: K. Subharaman YEAR OF INC: 1944 BSE CODE: 506690 FV (Rs): 2 DIV YIELD (%): 0.8

More Pharmaceuticals Company Fact Sheets:   INDRAPRASTHA MEDICAL  FULFORD INDIA  BIOCON LTD  GLENMARK PHARMA  CADILA HEALTHCARE  

Compare UNICHEM LAB With:   INDRAPRASTHA MEDICAL  FULFORD INDIA  BIOCON LTD  GLENMARK PHARMA  CADILA HEALTHCARE  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak End to the Week; Auto & PSU Stocks Fall(Closing)

Profit booking continued in the afternoon session in the Indian share markets amid weak European cues. At the closing bell, the BSE Sensex stood lower by 153 points.

Views on news

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

More Views on News

Most Popular

Digital Transactions were Growing Faster Before Demonetisation(Vivek Kaul's Diary)

Jun 12, 2017

Which brings us back to the basic question, why was demonetisation carried out?

A Pharma IPO in a Market That Loves IPOs but Hates Pharma(The 5 Minute Wrapup)

Jun 15, 2017

Tomorrow comes the IPO of Eris Lifesciences. How will a pharma IPO do in this market?

Get Ready for Commodity Options!(Daily Profit Hunter)

Jun 16, 2017

Commodity options trading is one step closer to reality. Learn how to take advantage of this tremendous opportunity.

Should You Trade In Mutual Funds As You Do In Stocks?(Outside View)

Jun 10, 2017

Trading is not synonymous with mutual funds, PersonalFN explains.

Which Way Will Inflation Go?(Chart Of The Day)

Jun 10, 2017

RBI and government at loggerheads over interest rates.

More

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON UNICHEM LAB

UNICHEM LAB - ADCOCK INGRAM COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS